60 Degrees Pharmaceuticals, Inc. (SXTP)

SXTP Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020
Cash & Equivalents	2.14	0.26	0.12	0.2
Cash & Cash Equivalents	2.14	0.26	0.12	0.2
Cash Growth	708.90%	129.52%	-42.66%	-
Receivables	0.23	0.05	0.15	0.86
Inventory	0.47	0.52	0.69	1.04
Other Current Assets	4.4	0.27	0.23	0.34
Total Current Assets	7.24	1.1	1.18	2.44
Property, Plant & Equipment	0.07	0.03	0.11	0.07
Goodwill and Intangibles	0.23	0.16	0.11	0.08
Other Long-Term Assets	0.24	0	0	0.01
Total Long-Term Assets	0.54	0.2	0.22	0.16
Total Assets	7.78	1.3	1.39	2.61
Accounts Payable	0.51	0.76	0.59	1.38
Current Debt	0.02	21.34	0.05	0
Other Current Liabilities	2.31	1.82	0	0.06
Total Current Liabilities	2.84	23.92	0.64	1.43
Long-Term Debt	0.15	1.27	18.76	19.14
Other Long-Term Liabilities	0	0.26	0.15	0.1
Total Long-Term Liabilities	0.15	1.53	18.91	19.24
Total Liabilities	2.99	25.45	19.55	20.68
Total Debt	0.17	22.61	18.8	19.14
Debt Growth	-99.24%	20.25%	-1.76%	-
Retained Earnings	-32.58	-28.82	-22.63	-18.38
Comprehensive Income	0.14	0.07	0.08	0.08
Shareholders' Equity	4.87	-23.58	-17.58	-17.5
Net Cash / Debt	1.97	-22.35	-18.69	-18.94
Net Cash Per Share	0.50	-9.44	-	-
Working Capital	4.41	-22.82	0.54	1.01
Book Value Per Share	1.23	-9.96	-7.37	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).